Is Amlodipine/Hydrochlorothiazide/Valsartan (Exforge HCT) in shortage in 2026? Here's what patients need to know about availability, cost, and options.
If you take Amlodipine/Hydrochlorothiazide/Valsartan — the triple-combination blood pressure pill sold as Exforge HCT — you may have struggled to fill your prescription at some point. You're not alone. While this medication isn't officially listed as "in shortage" by the FDA right now, many patients across the country report difficulty finding it at their local pharmacy.
In this shortage update, we'll cover the current situation, why this keeps happening, what the medication costs in 2026, and what you can do to make sure you don't miss a dose.
As of early 2026, Amlodipine/Hydrochlorothiazide/Valsartan is not formally listed on the FDA's drug shortage database or the ASHP (American Society of Health-System Pharmacists) shortage list. However, "not in shortage" on paper doesn't always match reality at the pharmacy counter.
Here's what's actually happening:
The bottom line: while it's not a nationwide emergency shortage, availability is spotty, and many patients face real difficulty getting their prescriptions filled without extra effort.
Several factors continue to affect the supply of this medication:
The massive 2018 Valsartan recall — triggered by the discovery of NDMA impurities in products from overseas manufacturers — permanently changed the landscape. Some generic manufacturers left the Valsartan market entirely, and the number of companies producing Amlodipine/Valsartan/HCTZ combination tablets remains limited.
Triple-combination antihypertensives represent a relatively small market. Most patients with high blood pressure take one or two medications, not three. From a business standpoint, generic manufacturers prioritize higher-volume products, which means fewer companies are competing to make this triple combo.
Modern pharmacies use "just in time" inventory systems, ordering medications based on expected demand. Because Amlodipine/Hydrochlorothiazide/Valsartan is less commonly dispensed, many pharmacies don't keep it on the shelf unless they have regular patients filling it.
Cost can vary significantly depending on whether you have insurance and which version you're filling:
If cost is a barrier, read our full guide on how to save money on Amlodipine/Hydrochlorothiazide/Valsartan.
While no brand-new triple-combination blood pressure medications have launched recently, patients have more options than ever:
If your pharmacy doesn't have it, here's your action plan:
For a detailed walkthrough, see our guide on how to find Amlodipine/Hydrochlorothiazide/Valsartan in stock near you.
The Amlodipine/Hydrochlorothiazide/Valsartan supply situation in 2026 is better than it was during the worst of the Valsartan recall era — but it's far from perfect. Certain strengths remain difficult to find, and patients shouldn't have to work this hard to fill a blood pressure prescription.
Stay proactive: refill early, use Medfinder to check availability, and keep an open line of communication with your doctor and pharmacist. Your blood pressure won't manage itself, and staying on top of your medication supply is a key part of staying healthy.
For information on side effects, visit our guide on Amlodipine/Hydrochlorothiazide/Valsartan side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
